Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
25.90
+2.55 (10.92%)
At close: Mar 9, 2026, 4:00 PM EDT
25.48
-0.42 (-1.62%)
After-hours: Mar 9, 2026, 6:56 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $12.81 billion as of March 9, 2026. Its market cap has increased by 23,905.04% in one year.
Market Cap
12.81B
Enterprise Value
12.21B
1-Year Change
23,905.04%
Ranking
Category
Stock Price
$25.90
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $12.81B, an increase of 10,563.83%. That is a compound annual growth rate of 173.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.55B | 11.19% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 36.16B |
| United Therapeutics | 20.96B |
| Viatris | 16.30B |
| Neurocrine Biosciences | 12.86B |
| Dr. Reddy's Laboratories | 11.81B |
| Elanco Animal Health | 11.61B |
| Alkermes | 4.77B |
| Lantheus Holdings | 4.69B |